Archford Capital Strategies, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Archford Capital Strategies, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 20, 2022	SELL	$543.48 - $670.97 $527,719 - $651,511	-971 Closed	0 $0
Q3 2021 Oct 14, 2021	BUY	$574.03 - $680.96 $9,184 - $10,895	16 Added 1.68%	971 $588,000
Q2 2021 Jul 23, 2021	BUY	$472.8 - $558.54 $29,786 - $35,188	63 Added 7.06%	955 $533,000
Q1 2021 Apr 26, 2021	BUY	$446.73 - $548.2 $118,830 - $145,821	266 Added 42.49%	892 $441,000
Q4 2020 Jan 19, 2021	BUY	$478.3 - $607.98 $92,790 - $117,948	194 Added 44.91%	626 $312,000
Q3 2020 Oct 19, 2020	SELL	$544.75 - $658.21 $67,004 - $80,959	-123 Reduced 22.16%	432 $242,000
Q2 2020 Jul 24, 2020	BUY	$493.32 - $643.92 $35,519 - $46,362	72 Added 14.91%	555 $346,000
Q1 2020 Apr 29, 2020	BUY	$336.18 - $494.43 $162,374 - $238,809	483 New	483 $236,000

1,529

84.1M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $81.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Archford Capital Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Archford Capital Strategies, LLC with notifications on news.